Table 2.
Issue | Jeremic et al. | CREST | Comments |
---|---|---|---|
Importance of improved LC | Yes | Yes | Leads to improved OS |
Tempo of achieving improvement of LC | Faster | Slower | Leads to a faster improvement of OS in Jeremic et al. |
OTT | Shorter | Longer | Possible due to better patient characteristics in Jeremic et al. |
Incidence of high-grade toxicity | 5% (lung) 20% (esophagus) | 1.2% (lung) 1.6% (esophagus) | Higher TRT doses and concurrent CHT in Jeremic et al. |
Duration of CHT | Shorter | Longer | Shorter appropriate in favorable patients? |
LC, local control; OS, overall survival; OTT, overall treatment time; TRT, thoracic radiotherapy; CHT, chemotherapy.